Nuvectis Pharma Inc (NVCT)
10.22 -0.43 (-4.04%) 10:25 ET [NASDAQ]
10.22 x 700 10.33 x 200
Realtime by (Cboe BZX)
10.22 x 700 10.33 x 200
Realtime 10.42 -0.23 (-2.16%) 07:12 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NVCT | MNPR | FHTX | ||
| Company | Nuvectis Pharma Inc | Monopar Therapeutics Inc | Foghorn Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.44 | 40.37 | 4.39 | ||
| High | 11.08 | 42.00 | 4.39 | ||
| Low | 10.21 | 40.37 | 4.24 | ||
| Last | 10.22 | 41.52 | 4.27 | ||
| Change | -0.43 | +0.71 | -0.12 | ||
| % Change | -4.04% | +1.74% | -2.73% | ||
| Volume | 18,774 | 5,870 | 7,563 | ||
| 20-Day Average Volume | 131,404 | 21,602 | 124,375 | ||
| Previous Close | 10.65 | 40.81 | 4.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.27 | 37.18 | 3.76 | ||
| 20-Day Raw Stochastic | 69.30% | 76.50% | 74.80% | ||
| 20-Day Relative Strength | 57.73% | 54.74% | 52.80% | ||
| Weighted Alpha | +99.95 | +214.88 | -46.53 | ||
| Today's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.33% since 04/22/25 | -4.16% since 04/22/25 | +1.65% since 04/22/25 | ||
| Low | 9.10 on 04/23/25 | 39.35 on 04/24/25 | 4.23 on 04/25/25 | ||
| High | 11.52 on 04/28/25 | 45.82 on 04/25/25 | 4.77 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -1.34% since 03/28/25 | +2.10% since 03/28/25 | +22.44% since 03/28/25 | ||
| Low | 7.61 on 04/07/25 | 26.06 on 04/09/25 | 2.94 on 04/03/25 | ||
| High | 11.52 on 04/28/25 | 45.82 on 04/25/25 | 4.77 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | +62.01% since 01/29/25 | +6.12% since 01/29/25 | +8.29% since 01/29/25 | ||
| Low | 5.81 on 02/05/25 | 26.06 on 04/09/25 | 2.94 on 04/03/25 | ||
| High | 11.52 on 04/28/25 | 54.30 on 02/10/25 | 6.66 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | +31.13% since 10/29/24 | +154.01% since 10/29/24 | -47.25% since 10/29/24 | ||
| Low | 4.44 on 12/23/24 | 12.55 on 10/31/24 | 2.94 on 04/03/25 | ||
| High | 11.80 on 11/12/24 | 54.30 on 02/10/25 | 9.70 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 249,125 | 249,455 | 244,137 | ||
| Shares Outstanding, K | 23,392 | 6,113 | 55,612 | ||
| Annual Sales | 0 | 0 | 22,600,000 | ||
| Annual Net Income | -19,000,000 | -15,590,000 | -86,620,000 | ||
| Last Quarter Sales | 0 | 0 | 2,860,000 | ||
| Last Quarter Net Income | -6,250,000 | -10,930,000 | -19,500,000 | ||
| 60-Month Beta | -0.11 | 1.01 | 3.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 02/25/25 | -2.23 on 03/31/25 | -0.30 on 03/06/25 | ||
| Latest Earnings Date | 05/06/25 | 05/08/25 | 05/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||